Balance Sheet Shenzhen YHLO Biotech Co., Ltd.

Stocks

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 09/06/2026			5-day change	1st Jan Change
9.500 ^CNY	-0.42%		-9.61%	-33.10%

05-17	Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2026.	CI
04-28	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

61b00366b6f12e53c55ed50ab9ce.--dnCq0yoWSRyhCaXXPipdFIjeD42EnQ19KTa9WF8Wg.johVR5Vk6grEhVmrHiul74Y7ure5mgGyoLXhHJK3ulursTZbznzzO_yBRQ

Published financial data: SHENZHEN YHLO BIOTECH CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.13B	3.93B	2.02B	1.97B	1.76B
Other Revenues, Total	44.37M	51.13M	34.69M	37.93M	46.26M
Total Revenues	1.18B	3.98B	2.05B	2.01B	1.81B
Cost of Goods Sold, Total	524M	1.94B	949M	720M	661M
Gross Profit	654M	2.04B	1.1B	1.29B	1.15B
Selling General & Admin Expenses, Total	303M	618M	565M	607M	643M
Provision for Bad Debts	2.88M	11.52M	7.5M	10.58M	7.47M
R&D Expenses	129M	238M	314M	331M	300M
Other Operating Expenses	8.09M	30.2M	1.57M	7.2M	10.3M
Other Operating Expenses, Total	443M	898M	888M	956M	960M
Operating Income	211M	1.15B	216M	335M	190M
Interest Expense, Total	-11.22M	-8.41M	-6.25M	-12.18M	-22.89M
Interest And Investment Income	8.33M	14.4M	132M	4.86M	6.03M
Net Interest Expenses	-2.89M	5.99M	126M	-7.33M	-16.86M
Currency Exchange Gains (Loss)	-2.76M	9.71M	3.06M	-735K	-3.01M
Other Non Operating Income (Expenses)	-858K	-23.65M	-1.59M	-3.2M	-2.99M
EBT, Excl. Unusual Items	204M	1.14B	343M	324M	167M
Gain (Loss) On Sale Of Investments	146K	54.45M	-32.73M	-31.52M	-67.34M
Gain (Loss) On Sale Of Assets	-	-3.39M	2.07M	1.82M	336K
Asset Writedown	-200K	-10.33M	-9.08M	-10.84M	-3.73M
Other Unusual Items	23.75M	7.8M	30.67M	28.05M	-1.62M
EBT, Incl. Unusual Items	228M	1.19B	334M	312M	94.47M
Income Tax Expense	23.91M	165M	54.91M	39.5M	26.14M
Earnings From Continuing Operations	204M	1.02B	279M	272M	68.34M
Net Income to Company	204M	1.02B	279M	272M	68.34M
Minority Interest	901K	-9.13M	75.81M	29.34M	-45M
Net Income - (IS)	205M	1.01B	355M	302M	23.34M
Net Income to Common Incl Extra Items	205M	1.01B	355M	302M	23.34M
Net Income to Common Excl. Extra Items	205M	1.01B	355M	302M	23.34M
Per Share Items
Net EPS - Basic	0.38	1.79	0.63	0.53	0.04
Basic EPS - Continuing Operations	0.38	1.79	0.63	0.53	0.04
Basic Weighted Average Shares Outstanding	541M	566M	564M	569M	584M
Net EPS - Diluted	0.38	1.78	0.62	0.53	0.04
Diluted EPS - Continuing Operations	0.38	1.78	0.62	0.53	0.04
Diluted Weighted Average Shares Outstanding	541M	569M	573M	570M	584M
Normalized Basic EPS	0.24	1.24	0.52	0.41	0.1
Normalized Diluted EPS	0.24	1.23	0.51	0.41	0.1
Dividend Per Share	0.29	0.45	0.27	0.21	0.02
Payout Ratio	5.32	16.69	79.58	56.06	606.57
Supplemental Items
EBITDA	304M	1.28B	398M	575M	474M
EBITA	217M	1.16B	236M	358M	213M
EBIT	211M	1.15B	216M	335M	190M
EBITDAR	311M	1.29B	410M	591M	489M
Total Revenues (As Reported)	-	3.98B	2.05B	2.01B	1.81B
Effective Tax Rate - (Ratio)	10.5	13.9	16.43	12.67	27.67
Total Current Taxes	27.16M	184M	59.29M	40.35M	33.12M
Total Deferred Taxes	-3.25M	-19.12M	-4.38M	-848K	-6.98M
Normalized Net Income	128M	702M	290M	232M	59.27M
Interest Capitalized	849M	5.38M	17.26M	8.96M	2.18M
Non-Cash Pension Expense	265K	974K	1.03M	4.3M	9M
Supplemental Operating Expense Items
Advertising Expense	23.15M	188M	36.49M	31.66M	34.73M
Marketing Expenses	3.56M	905K	2.38M	6.19M	671K
Selling and Marketing Expenses	214M	483M	386M	425M	438M
General and Administrative Expenses	85.21M	131M	172M	172M	194M
Research And Development Expense From Footnotes	131M	240M	317M	337M	305M
Net Rental Expense, Total	7.19M	8.24M	12.06M	15.64M	14.95M
Imputed Operating Lease Interest Expense	180M	2.57M	4.4M	3.61M	3.33M
Imputed Operating Lease Depreciation	-173M	5.67M	7.66M	12.02M	11.62M
Maintenance & Repair Expenses, Total	-	8.12M	5.4M	5.3M	5.68M
Stock-Based Comp., R&D Exp. (Total)	-	9.18M	5.05M	7.35M	2.13M
Stock-Based Comp., S&M Exp. (Total)	-	5.62M	4.67M	3.68M	966K
Stock-Based Comp., G&A Exp. (Total)	-	6.6M	3.68M	5.06M	12.07M
Total Stock-Based Compensation	-	21.41M	13.4M	16.09M	15.16M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	479M	1.25B	491M	465M	407M
Short Term Investments	-	68.57M	144M	182M	163M
Trading Asset Securities, Total	16.15M	114M	76.66M	69.59M	116M
Total Cash And Short Term Investments	495M	1.43B	711M	717M	687M
Accounts Receivable, Total	254M	346M	414M	524M	596M
Other Receivables	10.41M	66.2M	48.11M	54.23M	43.93M
Total Receivables	265M	413M	462M	578M	640M
Inventory	364M	570M	635M	671M	602M
Other Current Assets, Total	54.4M	79.72M	43.08M	45.98M	44.34M
Total Current Assets	1.18B	2.5B	1.85B	2.01B	1.97B
Gross Property Plant And Equipment	916M	1.42B	1.89B	2.44B	2.69B
Accumulated Depreciation	-244M	-372M	-514M	-704M	-934M
Net Property Plant And Equipment	672M	1.04B	1.37B	1.74B	1.76B
Long-term Investments	75.42M	303M	261M	358M	249M
Goodwill	-	5.29M	5.29M	5.29M	5.29M
Other Intangibles, Total	104M	210M	189M	183M	161M
Accounts Receivable Long-Term	3.76M	-	-	-	-
Deferred Tax Assets Long-Term	16.81M	48.42M	47.68M	44.01M	48.92M
Deferred Charges Long-Term	22.87M	36.15M	43.12M	26.97M	27.46M
Other Long-Term Assets, Total	65.05M	69.9M	37.89M	51M	63.41M
Total Assets	2.14B	4.21B	3.81B	4.42B	4.29B
Liabilities
Accounts Payable, Total	138M	308M	204M	213M	143M
Accrued Expenses, Total	54.88M	211M	146M	164M	133M
Short-term Borrowings	151M	279M	171M	292M	279M
Current Portion of Long-Term Debt	-	-	-	23.8M	27.51M
Current Portion of Leases	4.73M	5.05M	1.07M	1.84M	1.03M
Current Income Taxes Payable	12.27M	75.73M	13.27M	4.59M	18.3M
Unearned Revenue Current, Total	111M	529M	184M	184M	149M
Other Current Liabilities	40.79M	126M	123M	173M	173M
Total Current Liabilities	512M	1.53B	841M	1.06B	924M
Long-Term Debt	73.26M	184M	382M	585M	588M
Long-Term Leases	4.89M	5.24M	3.57M	2.39M	66.12K
Unearned Revenue Non Current	33.25M	29.75M	36.7M	62.52M	84.48M
Deferred Tax Liability Non Current	21.97K	14.1M	9.06M	4.54M	2.47M
Other Non Current Liabilities	-	-	-	740K	2.28M
Total Liabilities	624M	1.77B	1.27B	1.71B	1.6B
Common Stock, Total	405M	567M	568M	570M	571M
Additional Paid In Capital	525M	390M	432M	480M	519M
Retained Earnings	596M	1.45B	1.55B	1.69B	1.6B
Comprehensive Income and Other	-120K	13.84M	13.53M	14.38M	11.7M
Total Common Equity	1.53B	2.42B	2.56B	2.76B	2.7B
Minority Interest	-11.49M	28.13M	-26.27M	-55.32M	-9.96M
Total Equity	1.51B	2.44B	2.53B	2.7B	2.69B
Total Liabilities And Equity	2.14B	4.21B	3.81B	4.42B	4.29B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	567M	567M	568M	570M	571M
ECS Total Common Shares Outstanding	567M	567M	568M	570M	571M
Book Value / Share	2.69	4.26	4.51	4.83	4.72
Tangible Book Value	1.42B	2.2B	2.37B	2.57B	2.53B
Tangible Book Value Per Share	2.51	3.88	4.16	4.5	4.43
Total Debt	234M	474M	558M	906M	896M
Net Debt	-261M	-960M	-153M	189M	209M
Debt Equivalent Oper. Leases	57.51M	65.94M	96.48M	125M	120M
Minority Interest, Total (Incl. Fin. Div)	-11.49M	28.13M	-26.27M	-55.32M	-9.96M
Equity Method Investments, Total	35.05M	45.47M	140M	143M	125M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	122M	291M	253M	202M	187M
Inventories - Work In Process, Total	51.03M	48.08M	148M	129M	119M
Inventories - Finished Goods, Total	201M	310M	350M	362M	324M
Buildings, Total	222M	322M	343M	892M	1.05B
Machinery, Total	583M	818M	1.07B	1.37B	1.63B
Full Time Employees	-	1.84K	1.76K	-	1.66K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	14.25M	24.53M	24.07M	38.55M	45.7M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	205M	1.01B	355M	302M	23.34M
Depreciation & Amortization - CF	90.98M	132M	175M	222M	262M
Amortization of Goodwill and Intangible Assets - (CF)	6.49M	10.94M	19.99M	22.92M	23.29M
Depreciation & Amortization, Total	97.47M	143M	195M	245M	286M
Amortization of Deferred Charges, Total - (CF)	7.06M	31.74M	15.63M	11.2M	12.35M
(Gain) Loss From Sale Of Asset	-	3.39M	-2.07M	-1.82M	336K
(Gain) Loss on Sale of Investments - (CF)	2.82M	-59.84M	-85.35M	31.52M	67.34M
Asset Writedown & Restructuring Costs	200K	10.33M	9.08M	9.71M	3.74M
Provision and Write-off of Bad Debts	2.88M	11.07M	7.5M	10.58M	8.5M
Other Operating Activities, Total	26.25M	115M	-11.46M	-909K	88.46M
Change In Accounts Receivable	-54.96M	-190M	12.93M	-131M	-79.39M
Change In Inventories	-67.37M	-341M	-102M	5.8M	90.09M
Change In Accounts Payable	43.78M	843M	-477M	33.01M	-86.71M
Change In Deferred Taxes	-3.25M	-17.53M	-3.93M	-848K	-6.99M
Change in Other Net Operating Assets	-	21.41M	13.49M	15.64M	15.05M
Cash from Operations	260M	1.58B	-73.19M	530M	422M
Capital Expenditure	-373M	-565M	-663M	-593M	-359M
Sale of Property, Plant, and Equipment	-	30K	58.91K	22.9K	63.68K
Cash Acquisitions	-	-6.3M	-	-26.44K	-
Divestitures	-	-	-21.57M	-	729K
Investment in Marketable and Equity Securities, Total	-91.68M	-280M	22.25M	-161M	-961K
Other Investing Activities, Total	3.27M	-17.71M	27.1M	5.5M	24.85M
Cash from Investing	-461M	-870M	-635M	-749M	-335M
Long-Term Debt Issued, Total	368M	683M	530M	572M	869M
Total Debt Issued	368M	683M	530M	572M	869M
Long-Term Debt Repaid, Total	-454M	-450M	-288M	-233M	-873M
Total Debt Repaid	-454M	-450M	-288M	-233M	-873M
Issuance of Common Stock	562M	-	17.26M	21.11M	10.32M
Common Dividends Paid	-10.9M	-169M	-283M	-169M	-142M
Common & Preferred Stock Dividends Paid	-10.9M	-169M	-283M	-169M	-142M
Other Financing Activities, Total	-17.15M	-51.03M	3.61M	-11.17M	-15.28M
Cash from Financing	448M	13.47M	-19.26M	181M	-151M
Foreign Exchange Rate Adjustments	-1.41M	10.25M	3.98M	-6M	-923K
Net Change in Cash	245M	737M	-723M	-43.92M	-64.35M
Supplemental Items
Cash Income Tax Paid (Refund)	80.03M	234M	146M	107M	118M
Levered Free Cash Flow	-122M	856M	-966M	-203M	-56.76M
Unlevered Free Cash Flow	-115M	861M	-962M	-196M	-42.46M
Change In Net Working Capital	-21.26M	-514M	658M	84.35M	115M
Net Debt Issued / Repaid	-86.17M	234M	242M	340M	-4.18M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.6	22.56	3.36	5.1	2.72
Return on Total Capital	9.31	30.7	4.48	6.26	3.3
Return On Equity %	17.9	51.61	11.22	10.4	2.54
Return on Common Equity	17.85	51.36	14.27	11.34	0.86
Margin Analysis
Gross Profit Margin %	55.49	51.34	53.77	64.2	63.51
SG&A Margin	25.7	15.52	27.54	30.2	35.5
EBITDA Margin %	25.81	32.25	19.37	28.58	26.16
EBITA Margin %	18.43	29.06	11.47	17.82	11.76
EBIT Margin %	17.88	28.79	10.5	16.68	10.48
Income From Continuing Operations Margin %	17.31	25.66	13.6	13.53	3.77
Net Income Margin %	17.38	25.43	17.29	14.99	1.29
Net Avail. For Common Margin %	17.38	25.43	17.29	14.99	1.29
Normalized Net Income Margin	10.9	17.64	14.14	11.53	3.27
Levered Free Cash Flow Margin	-10.38	21.49	-47.06	-10.11	-3.13
Unlevered Free Cash Flow Margin	-9.79	21.63	-46.87	-9.73	-2.34
Asset Turnover
Asset Turnover	0.68	1.25	0.51	0.49	0.42
Fixed Assets Turnover	2.15	4.64	1.7	1.3	1.04
Receivables Turnover (Average Receivables)	4.84	13.08	5.31	4.21	3.15
Inventory Turnover (Average Inventory)	1.58	4.15	1.58	1.1	1.04
Short Term Liquidity
Current Ratio	2.3	1.63	2.2	1.9	2.13
Quick Ratio	1.48	1.2	1.39	1.22	1.44
Operating Cash Flow to Current Liabilities	0.51	1.03	-0.09	0.5	0.46
Days Sales Outstanding (Average Receivables)	75.35	27.9	68.77	86.97	115.84
Days Outstanding Inventory (Average Inventory)	230.44	87.94	231.53	331.72	351.57
Average Days Payable Outstanding	65.38	37.93	92.07	100.88	109.8
Cash Conversion Cycle (Average Days)	240.41	77.91	208.23	317.82	357.61
Long Term Solvency
Total Debt/Equity	15.43	19.37	22.01	33.53	33.34
Total Debt / Total Capital	13.37	16.23	18.04	25.11	25
LT Debt/Equity	5.16	7.74	15.21	21.76	21.88
Long-Term Debt / Total Capital	4.47	6.48	12.47	16.29	16.41
Total Liabilities / Total Assets	29.17	41.95	33.43	38.81	37.34
EBIT / Interest Expense	18.77	136.31	34.47	27.53	8.29
EBITDA / Interest Expense	27.45	153.31	65.64	47.64	20.77
(EBITDA - Capex) / Interest Expense	-5.76	86.06	-40.33	-1.05	5.08
Total Debt / EBITDA	0.76	0.37	1.36	1.56	1.88
Net Debt / EBITDA	-0.85	-0.74	-0.37	0.33	0.44
Total Debt / (EBITDA - Capex)	-3.62	0.65	-2.21	-70.63	7.71
Net Debt / (EBITDA - Capex)	4.04	-1.33	0.61	-14.73	1.8
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.91	237.95	-48.42	-2.02	-9.99
Gross Profit, 1 Yr. Growth %	15.67	215.53	-45.98	16.98	-10.96
EBITDA, 1 Yr. Growth %	-8.61	313.88	-69.18	30.4	-18
EBITA, 1 Yr. Growth %	-18.67	427.78	-79.67	30.95	-41.02
EBIT, 1 Yr. Growth %	-20	443.48	-81.19	33.32	-43.55
Earnings From Cont. Operations, 1 Yr. Growth %	-1.98	401.12	-72.66	-2.51	-74.89
Net Income, 1 Yr. Growth %	-2.75	394.46	-64.92	-15.06	-92.26
Normalized Net Income, 1 Yr. Growth %	-16.57	446.64	-58.65	-25.05	-74.45
Diluted EPS Before Extra, 1 Yr. Growth %	-8.62	368.42	-65.17	-14.54	-92.45
Accounts Receivable, 1 Yr. Growth %	19.11	36.14	19.58	26.48	13.79
Inventory, 1 Yr. Growth %	22.01	56.55	11.41	5.72	-10.26
Net Property, Plant and Equip., 1 Yr. Growth %	58	55.3	31.4	26.51	1.48
Total Assets, 1 Yr. Growth %	61.51	97	-9.67	16	-2.86
Tangible Book Value, 1 Yr. Growth %	94.24	54.8	7.45	8.6	-1.48
Common Equity, 1 Yr. Growth %	98.71	58.39	5.91	7.7	-2.17
Cash From Operations, 1 Yr. Growth %	-7.99	509.8	-104.62	-824.03	-20.39
Capital Expenditures, 1 Yr. Growth %	96.77	51.71	17.22	-10.47	-39.45
Levered Free Cash Flow, 1 Yr. Growth %	1.06K	-800.72	-212.93	-78.46	-72.03
Unlevered Free Cash Flow, 1 Yr. Growth %	4.97K	-847.99	-211.78	-79.18	-78.27
Dividend Per Share, 1 Yr. Growth %	-	57.51	-39.33	-23.08	-90
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.87	99.62	32.02	-28.91	-6.09
Gross Profit, 2 Yr. CAGR %	22.39	90.18	30.56	-20.51	2.06
EBITDA, 2 Yr. CAGR %	30.2	96.43	13.24	-33.26	3.65
EBITA, 2 Yr. CAGR %	28.2	108.2	3.67	-44.39	-11.79
EBIT, 2 Yr. CAGR %	27.49	108.65	1.11	-45.89	-13.18
Earnings From Cont. Operations, 2 Yr. CAGR %	38.62	121.63	17.03	-48.37	-50.53
Net Income, 2 Yr. CAGR %	37.98	119.29	31.68	-45.42	-74.36
Normalized Net Income, 2 Yr. CAGR %	33.54	113.56	50.34	-42.52	-56.24
Diluted EPS Before Extra, 2 Yr. CAGR %	32.92	107.28	27.73	-45.44	-74.6
Accounts Receivable, 2 Yr. CAGR %	17.66	27.34	27.59	22.98	19.97
Inventory, 2 Yr. CAGR %	16.44	38.21	32.06	8.52	-2.6
Net Property, Plant and Equip., 2 Yr. CAGR %	37.63	56.65	42.85	28.93	13.31
Total Assets, 2 Yr. CAGR %	40.98	78.37	33.43	2.36	6.15
Tangible Book Value, 2 Yr. CAGR %	61.33	73.4	28.98	8.02	3.44
Common Equity, 2 Yr. CAGR %	62.27	77.41	29.53	6.81	2.65
Cash From Operations, 2 Yr. CAGR %	94.91	136.87	-46.91	-42.15	140.08
Capital Expenditures, 2 Yr. CAGR %	70.57	72.78	33.35	2.44	-26.37
Levered Free Cash Flow, 2 Yr. CAGR %	-7.82	802.43	181.3	-51.26	-75.48
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.88	1.85K	189.16	-52.32	-78.75
Dividend Per Share, 2 Yr. CAGR %	-	-	-2.25	-31.69	-72.26
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	17.36	65.55	27.14	19.53	-23.1
Gross Profit, 3 Yr. CAGR %	32.16	67.31	25.01	25.87	-17.44
EBITDA, 3 Yr. CAGR %	59.2	92.71	6.13	22.84	-28.4
EBITA, 3 Yr. CAGR %	60.96	106.13	-4.08	17.81	-43.14
EBIT, 3 Yr. CAGR %	61.94	106.81	-6.44	16.74	-45.09
Earnings From Cont. Operations, 3 Yr. CAGR %	75	112.75	10.32	10.12	-59.4
Net Income, 3 Yr. CAGR %	75.26	111.15	19.03	13.77	-71.54
Normalized Net Income, 3 Yr. CAGR %	67.32	113.62	23.54	21.78	-56.13
Diluted EPS Before Extra, 3 Yr. CAGR %	68.88	102.52	14.38	11.72	-71.78
Accounts Receivable, 3 Yr. CAGR %	18.03	23.52	24.7	27.22	19.84
Inventory, 3 Yr. CAGR %	21.38	28.52	28.63	22.62	1.86
Net Property, Plant and Equip., 3 Yr. CAGR %	32.14	43.29	47.73	37.18	19.04
Total Assets, 3 Yr. CAGR %	36.62	57.61	42.2	27.35	0.59
Tangible Book Value, 3 Yr. CAGR %	68.22	59.13	47.84	21.79	4.76
Common Equity, 3 Yr. CAGR %	66.12	60.97	49.39	21.8	3.73
Cash From Operations, 3 Yr. CAGR %	105.98	185.07	-36.23	26.85	-35.65
Capital Expenditures, 3 Yr. CAGR %	25.98	64.04	51.82	16.77	-14.03
Levered Free Cash Flow, 3 Yr. CAGR %	-	81.17	351.38	18.52	-59.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	86.4	650.68	19.35	-63.33
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-9.75	-64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	23.02	18.05	12.63
Gross Profit, 5 Yr. CAGR %	-	-	31.28	24.24	15.27
EBITDA, 5 Yr. CAGR %	-	-	39.47	26.23	7.32
EBITA, 5 Yr. CAGR %	-	-	35.25	22.1	-4.41
EBIT, 5 Yr. CAGR %	-	-	34.17	20.96	-6.34
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	48.99	20.74	-19.95
Net Income, 5 Yr. CAGR %	-	-	56.32	22.9	-35.59
Normalized Net Income, 5 Yr. CAGR %	-	-	60.31	26.35	-17.38
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	51.14	19.85	-37.35
Accounts Receivable, 5 Yr. CAGR %	-	-	21.77	23.3	22.78
Inventory, 5 Yr. CAGR %	-	-	25.54	20.11	15.09
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	36.32	37.36	32.86
Total Assets, 5 Yr. CAGR %	-	-	35.33	32.63	26.51
Tangible Book Value, 5 Yr. CAGR %	-	-	51.26	36.29	28.16
Common Equity, 5 Yr. CAGR %	-	-	50.38	36.61	28.57
Cash From Operations, 5 Yr. CAGR %	-	-	19.76	50.63	8.38
Capital Expenditures, 5 Yr. CAGR %	-	-	28.88	35.88	13.66
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	7.15	40.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	8.04	79.55